UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016160
Receipt number R000018758
Scientific Title Effect of Combined Physical Therapy for Patients with Lymphedema
Date of disclosure of the study information 2015/01/08
Last modified on 2018/06/27 12:17:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Combined Physical Therapy for Patients with Lymphedema

Acronym

Effect of CPT for Lymphedema

Scientific Title

Effect of Combined Physical Therapy for Patients with Lymphedema

Scientific Title:Acronym

Effect of CPT for Lymphedema

Region

Japan


Condition

Condition

Lymphedema

Classification by specialty

Vascular surgery Obstetrics and Gynecology Rehabilitation medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify the effect of combined physical therapy for patients with lymphedema.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Change of volume of lower extremity
Lymphedema severity score

Key secondary outcomes

QOL evaluation (SF-36, Euriqol)
Adverse event


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

6

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

group intensive combined physical therapy (feasibility study)

Interventions/Control_2

group maintenance combined physical therapy (feasibility study)

Interventions/Control_3

group of reinforcement of compression therapy (main study)

Interventions/Control_4

group of reinforcement of lymph-drainage therapy (main study)

Interventions/Control_5

group of reinforcement of exercise (main study)

Interventions/Control_6

standard therapy (main study)

Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. primary secondary lymphedema of unilateral leg

2. patient without intensive combined physical therapy within three months

3. more than 20 years

Key exclusion criteria

1. edema due to other causes

2. edema of upper extremities or body

3. stage 0-lymphedema
cancer patient

4. expected life time less than one years

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yukihiro Saito

Organization

Asahikawa Medical University

Division name

Dep. of Surg, Dev. of Vascular surgery

Zip code


Address

2-1-1-1 Midorigaoka-Higashi, Asahikawa, Hikkaido, Japan

TEL

0166-68-2494

Email

ys02067@asahikawa-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yukihiro Saito

Organization

Asahikawa Medical University

Division name

Dep. of Surg, Dev. of Vascular surgery

Zip code


Address

2-1-1-1 Midorigaoka-Higashi, Asahikawa, Hikkaido, Japan

TEL

0166-68-2494

Homepage URL


Email

ys02067@asahikawa-med.ac.jp


Sponsor or person

Institute

Asahikawa Medical University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour and Welfare of Japan

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 01 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2014 Year 10 Month 09 Day

Date of IRB


Anticipated trial start date

2014 Year 10 Month 09 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 01 Month 08 Day

Last modified on

2018 Year 06 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018758


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name